#NanoparticleCommunication seems pretty high tech — but Alejandra Estepa and co-authors took it further, targeting #TNBC tumors with a strategy that involves nanoparticle-cell-nanoparticle communication through #stigmergy. Read more 📕: bit.ly/3tZuLtn

Santa brought me this present for Christmas!! 🎁 Check here my last work!

Quibim joins #EUCAIM, a new European Commission project to create a federated infrastructure for #imagingdata to fight against cancer connecting hospitals and repositories to improve early detection and treatment options. bit.ly/402mZO3

Quibim keeps growing! We are looking for #newtalents in several roles. If you would be a good fit, please send us your CV or join the Talent Pool. #BeaQuibimer! bit.ly/3Fae7OD

Because every day should be #WomeninScienceDay let’s keep honoring all women who work in Quibim who have backgrounds in science since they are the ideal role model for younger generations. Would you like to join our team? Visit our careers page bit.ly/3Fae7OD

Really proud to form part of the #Quibim team!

📢 We seek collaborators providing retrospective datasets! In return, you will receive compensation, access to results, decision support tools, and authorship in publications. 📅Deadline: April 21 Learn more: chaimeleon.eu/news/chaimelon… #AIforCancer #ClinicalCollaboration #H2020

🎉RadioVal is welcoming external stakeholders! We are an #EUfunded project that aims to validate an #ArtificialIntelligence solution for #breastcancer treatment planning. Learn more about us via our website and fill in the form✍️to become our stakeholder: radioval.eu/news/open-call…

Really happy to have the opportunity to share the discussion with the participants to the EATRIS Summer School. #PrecisionMedicine is already a reality in the clinic, but taking advantage of the #AItools we can increase the benefits of the #patients.

Quibim and ImaginAbInc have teamed up to transform immune status diagnosis and #immunotherapy prediction. This partnership strives to boost accuracy and efficiency in response, ultimately improving patient outcomes. Read everything about it! bit.ly/3LsUDGa

Yesterday, our Project Manager, Alejandra Estepa, had the honor of presenting Quibim's state-of-the-art advancements and pioneering innovations in the medical imaging sector to students enrolled in the Master's Degree in Access to the Health Industry. In partnership with

Are you attending the #ASCO2023 meeting? We're presenting our groundbreaking work focusing on identifying an imaging signature that predicts progression-free survival (PFS) in locally advanced head and neck squamous cell carcinoma (LAHNSCC). We continue exploring the power of

Transforming #liverdisease #diagnosis: using Convolutional Neural Networks (CNN) for automatic liver #segmentation and #quantification in MRI imaging. Read more in our blog: bit.ly/3NaWT66 Stay tuned for more advancements in health tech! #AI #healthtech

Really interesting article sharing the benefits of radiomics in predicting the outcome of lymphoma patients using diagnostic baseline PET

Join the CHAIMELEON Project Open Challenges: A unique opportunity for scientists globally to advance cancer research using #AI. Prizes totaling up to €100,000 will be distributed among the winners. Are you interested? Click the link! eu1.hubs.ly/H04kPmS0

Save the date for our upcoming webinar: "Cancer Immunotherapy: Exploring Imaging for Immune Response Prediction" with Xtalks Webinars. Discover the future of immunotherapy, predictive biomarkers, CD8 T cells, and AI in response assessments. 🗓️ Date: Sep 27, 2023 🕑 Time: 2pm EDT For

Hi! I'm looking for industry and postdoc positions. High expertise in neuronal cultures, stereotactic surgeries, viral tracing, mouse behavior, brain histology and imaging. Strongly interested on neural plasticity for brain disease. Please share! 🧠🔬 #neurojob PostdocVoice

As we bid farewell to #ESMO2023 Congress, we are brimming with inspiration and insight. These days gathered minds from around the globe, fostering collaborations that will shape the future of #oncology. Keep the conversation, collaboration, and innovation going. Until next time,

We are thrilled to announce our participation at the 65th American Society of Hematology (ASH) Annual Meeting, currently being held in San Diego. Today we are proud to present our poster "CART-AI-Radiomics: Survival and Neurotoxicity Prediction in B-Cell Lymphoma Patients

📍 To end this week full of events, we are at #ESOI2024, in Valencia (our home city!) to discuss the latest advancements on #oncologycare. Swing by to say hi to our team and get a glimpse of the latest advancements in medical imaging applied to #cancer care.